Royal London Asset Management Ltd. Has $3.28 Million Holdings in DaVita Inc. (NYSE:DVA)

Royal London Asset Management Ltd. increased its stake in shares of DaVita Inc. (NYSE:DVA) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,926 shares of the company’s stock after acquiring an additional 1,242 shares during the quarter. Royal London Asset Management Ltd.’s holdings in DaVita were worth $3,279,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. SBI Securities Co. Ltd. bought a new position in shares of DaVita during the 4th quarter worth about $41,000. Quarry LP acquired a new stake in DaVita during the third quarter worth about $60,000. Venturi Wealth Management LLC increased its stake in DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock valued at $61,000 after acquiring an additional 152 shares during the period. Versant Capital Management Inc raised its holdings in DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of DaVita by 39.7% in the 4th quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after acquiring an additional 131 shares during the period. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Trading Up 1.6 %

Shares of DaVita stock opened at $150.56 on Tuesday. The stock has a market capitalization of $12.04 billion, a P/E ratio of 14.02, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 12-month low of $125.64 and a 12-month high of $179.60. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a 50-day simple moving average of $158.40 and a 200 day simple moving average of $157.57.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have recently issued reports on DVA. Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. StockNews.com lowered shares of DaVita from a “buy” rating to a “hold” rating in a report on Friday. Cowen reaffirmed a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $166.33.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.